Skip to main content


Success Stories: Hear from leaders calling Ireland home

A proven path

See all Success Stories
Toast
NetApp
Pfizer
MeiraGTx
Takeda
dōTERRA
Irish operation has become a strategic global engineering hub

Irish operation has become a strategic global engineering hub

Toast originally chose to invest in Ireland largely for its concentration of high-level technical capability; over the last several years, we’ve come to reap so many more benefits from our strategic investment here–ease of collaboration with other Toast teams, Irish hospitality, and more.

Company set up European HQ in Cork in 2022

Company set up European HQ in Cork in 2022

Cork has become the global hub of choice for international headquarters of technology companies, home to over 100 technology companies. With over 40,000 students across Cork’s two universities, NetApp’s decision to base its international headquarters in Cork provides access to a talent pool that is truly worthy of supporting the robust and evolving technology market. As well as being a part of the vibrant emerging business scene in Cork, NetApp’s hybrid working model means there are opportunities for technical and non-technical candidates across Ireland.

Leading global player has invested $9 bn+ in Irish operations

Leading global player has invested $9 bn+ in Irish operations

Pharmaceutical manufacturing in Ireland continues to perform very well contributing strongly to exports and economic growth and provides excellent career opportunities.

Gene therapy startup chooses Ireland for commercial-scale manufacturing

Gene therapy startup chooses Ireland for commercial-scale manufacturing

MeiraGTx’s Shannon facility is unique, not only in Ireland but globally, as it streamlines gene therapy development, testing and manufacturing capabilities together in-house. This significantly reduces the time to patients for advanced therapeutic products, with months or potentially years saved.” -

Varied functions in Ireland for Asia’s largest pharma company

Varied functions in Ireland for Asia’s largest pharma company

The Grange Castle site is growing from strength to strength thanks to a great team and strong investment in our people and technology. The treatment produced here will be delivered to patients within 72 hours of being released from Grange Castle which means we are closer to the patient than we have ever been and this brings a great sense of pride to our team.

Company chooses Cork as its first international manufacturing site

Company chooses Cork as its first international manufacturing site

Our presence in Ireland has created employment opportunities for skilled workers, improved our ability to respond to our customers’ needs, and dramatically reduced our environmental impact.